Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mevalonate metabolism governs cancer immune surveillance.
Gruenbacher G, Thurnher M. Gruenbacher G, et al. Oncoimmunology. 2017 Jul 27;6(10):e1342917. doi: 10.1080/2162402X.2017.1342917. eCollection 2017. Oncoimmunology. 2017. PMID: 29123952 Free PMC article. Review.
Regulation of mevalonate metabolism in cancer and immune cells.
Thurnher M, Gruenbacher G, Nussbaumer O. Thurnher M, et al. Among authors: gruenbacher g. Biochim Biophys Acta. 2013 Jun;1831(6):1009-15. doi: 10.1016/j.bbalip.2013.03.003. Epub 2013 Mar 21. Biochim Biophys Acta. 2013. PMID: 23524243 Review.
Mevalonate metabolism in cancer.
Gruenbacher G, Thurnher M. Gruenbacher G, et al. Cancer Lett. 2015 Jan 28;356(2 Pt A):192-6. doi: 10.1016/j.canlet.2014.01.013. Epub 2014 Jan 24. Cancer Lett. 2015. PMID: 24467965 Review.
T lymphocyte regulation by mevalonate metabolism.
Thurnher M, Gruenbacher G. Thurnher M, et al. Among authors: gruenbacher g. Sci Signal. 2015 Mar 31;8(370):re4. doi: 10.1126/scisignal.2005970. Sci Signal. 2015. PMID: 25829448 Review.
Mevalonate Metabolism in Immuno-Oncology.
Gruenbacher G, Thurnher M. Gruenbacher G, et al. Front Immunol. 2017 Dec 1;8:1714. doi: 10.3389/fimmu.2017.01714. eCollection 2017. Front Immunol. 2017. PMID: 29250078 Free PMC article. Review.
Novel aspects of mevalonate pathway inhibitors as antitumor agents.
Thurnher M, Nussbaumer O, Gruenbacher G. Thurnher M, et al. Among authors: gruenbacher g. Clin Cancer Res. 2012 Jul 1;18(13):3524-31. doi: 10.1158/1078-0432.CCR-12-0489. Epub 2012 Apr 23. Clin Cancer Res. 2012. PMID: 22529099 Review.
18 results